Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001352413-14-000004
Filing Date
2014-02-25
Accepted
2014-02-25 18:13:20
Documents
1
Period of Report
2014-02-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 11376
  Complete submission text file 0001352413-14-000004.txt   12667
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Capone Mark Christopher (Reporting) CIK: 0001352413 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 14642213